Recombinant Anti-FGFR1 x Anti-KLB Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-FGFR1 antibody are both extended with the scFv fragment from an anti-KLB antibody. This BsAb can bind two factors simultaneously and act as mimetic hormone (FGF21) . It is designed for the research of Type 2 diabetes therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY